Skip to main content
. 2004 Apr 19;2004(2):CD001774. doi: 10.1002/14651858.CD001774.pub2

LGOG.

Methods RCT
 1991‐1995
Participants 27 FIGO stage IIB‐IVA, bulky IB, IIA
Interventions CT + RT vs RT
CT: CDDP 60mg/m2 MTX 300 mg/m2 BLM 30 mg. Every 14 days for 3 cycles.
RT: External beam 50Gy over 39 days. Intracavitary 28Gy
Outcomes Survival
 Disease‐free survival
 Locor‐regional disease‐free survival
 Metastases‐free survival
Notes Treatment comparison 1
Risk of bias
Bias Authors' judgement Support for judgement
Allocation concealment (selection bias) Unclear risk B ‐ Unclear